COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence
Blood Transfus
.
2020 May;18(3):226-229.
doi: 10.2450/2020.0113-20.
Authors
Antonio Coppola
1
,
Maria Lombardi
2
,
Maria I Tassoni
2
,
Gaetano Carolla
2
,
Maurizio Tala
3
,
Rossella Morandini
3
,
Oriana Paoletti
3
,
Sophie Testa
3
Affiliations
1
Regional Reference Center for Inherited Bleeding Disorders, University Hospital of Parma, Parma, Italy.
2
Internal Medicine, Angiology and Coagulation Unit, University Hospital of Parma, Parma, Italy.
3
Haemostasis and Thrombosis Center, Cremona Hospital, Cremona, Italy.
PMID:
32453688
PMCID:
PMC7250684
DOI:
10.2450/2020.0113-20
No abstract available
Publication types
Comment
MeSH terms
Anticoagulants
Betacoronavirus
COVID-19
Coronavirus Infections
Coronavirus*
Humans
Pandemics
Pneumonia, Viral*
SARS-CoV-2
Substances
Anticoagulants